Compare Bio Protocol (BIO) vs Raydium (RAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Raydium — how do they compare? Bio Protocol trades at Rp441.58 (market cap Rp998,02M, Rp177,99M 24h volume), while Raydium trades at Rp11,213 (market cap Rp3,01T, Rp123,66M 24h volume). The key difference: Raydium is far larger — about 3016× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 269,5M / 555M RAY (49%) for Raydium. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Raydium for 25 Days on average.
| BIO | RAY | |
|---|---|---|
Market Cap | Rp998,02M | Rp3,01T |
Volume (24h) | Rp177,99M | Rp123,66M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 269,5M / 555M RAY (49%) |
Typical Hold Time | 18 Days | 25 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
RAY is trading at Rp11,527 with a market cap of Rp3.05 trillion, showing neutral technical signals amid bearish moving averages. Recent news highlights include surpassing Rp1 quadrillion in trading volume after listings on Robinhood and Revolut, and enabling tokenized SpaceX stock trading on Solana, boosting ecosystem utility.
Outlook is cautiously optimistic due to increased exchange adoption and innovative use cases, but risks include high volatility and regulatory uncertainty. Key opportunities lie in Solana ecosystem growth, while major risks involve market manipulation and liquidity fluctuations.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Raydium
Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →
